Brii Biosciences Ltd (HKSE:02137)
HK$ 1.07 0.02 (1.9%) Market Cap: 782.15 Mil Enterprise Value: -1.80 Bil PE Ratio: 0 PB Ratio: 0.25 GF Score: 36/100

Full Year 2021 Brii Biosciences Ltd Earnings Call Transcript

Mar 23, 2022 / 12:00PM GMT
Release Date Price: HK$10.84 (-4.24%)
Operator

Good day, ladies and gentlemen, and thank you for standing by, and welcome to Brii Biosciences Limited 2021 Annual Results and Business Update Conference Call. (Operator Instructions)

It is now my pleasure to turn the call over to Ms. Chris Fang, Director of Investor Relations. Please go ahead, Chris.

Chris Fang
Brii Biosciences Limited - Director, IR

Thank you, operator. Welcome to Brii Bio's 2021 Annual Results and Business Update Conference Call. Our annual results announcement can be found on the Investor Relations section of our company website.

Joining today on the call from Brii Bio's senior management team are Dr. Zhi Hong, our Co-Founder, Chairman and Chief Executive Officer; Mr. Rogers Luo, our President and General Manager of Greater China; Dr. Li Yan, our Chief Medical Officer; and Dr. Ankang Li, our Chief Financial and Strategy Officer.

Dr. Hong will provide a high-level overview of our key programs, company strategy and future development plans; followed by Mr. Luo, who will summarize further details about our HBV and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot